The grant will fund a travelling Young People’s Community Worker (YPCW), attached to the CLIC Sargent team at the specialist Royal Marsden Hospital in Sutton, for the next two years. The YPCW will make sure that younger patients at general hospitals in the region, who are often treated on wards with patients decades older than them, get the support they need.
Rachel Alfieri, CLIC Sargent, explains: “Being treated on an adult cancer ward alongside people much older than you and dealing with the impact of the disease on your life when you are young can be a lonely and confusing experience.
“But thanks to this new funding our Young People’s Community Worker will be able to provide them with the age-appropriate support they need to cope with the devastating impact of cancer on their lives.
“That could be help with dealing with the financial impact of cancer on their lives, somebody to talk through worries with, or somebody to liaise on their behalf about housing, college or work issues.
“The funding for this post really is a lifeline for young cancer patients, and we’re so grateful to the Masonic Charitable Foundation for its support.”
CLIC Sargent is the UK’s leading cancer support charity for children and young people and their families. Its specialist teams provide practical, emotional, clinical, and financial support from diagnosis onwards for children and young people with cancer, and their families across the UK.
Kate Lee, CEO, CLIC Sargent, said: “When a young person is diagnosed with cancer, their world is turned upside down overnight, and every aspect of their life can be affected.
"By funding the work of our CLIC Sargent Young People's Community Worker at the Royal Marsden Hospital for the next two years, the Masonic Charitable Foundation will make a huge difference to the lives of around 60 young people with cancer, enabling us provide emotional, financial and practical support in a way that suits them.”
David Innes, CEO, Masonic Charitable Foundation, said: “The CLIC Sargent team do a fantastic job supporting young cancer patients through the hardest of times - and we’re proud to be funding this important work.”